Aeon announced EUR 8.2 million in seed financing to expand its preventive-health service across Europe. Concentric led the round, joined by Calm/Storm Ventures, GoHub Ventures, Kadmos Capital, EWOR and investor Daniel Gutenberg.
The Zurich-area company combined whole-body MRI, blood biomarkers, genetic information and physician review in a single assessment. It planned to use the proceeds for expansion in Switzerland, Germany and the UK, development of its AI platform, and partnerships with insurers and employers.
